Maternal Death Due to COVID-19

Background: Despite 2.5 million infections and 169,000 deaths worldwide (as of April 20, 2020), no maternal deaths and only a few pregnant women afflicted with severe respiratory morbidity have been reported to be related to COVID-19 disease. Given the disproportionate burden of severe and fatal respiratory disease previously documented among pregnant women following other coronavirus-related outbreaks (SARS-CoV in 2003 and MERS-CoV in 2012) and influenza pandemics over the last century, the absence of reported maternal morbidity and mortality with COVID-19 disease is unexpected.

Objective: To describe maternal and perinatal outcomes and death in a case series of pregnant women with COVID-19 disease.

Study Design: We describe here a multiinstitution adjudicated case series from Iran that includes 9 pregnant women diagnosed with severe COVID-19 disease in their second or third trimester. All 9 pregnant women received a diagnosis of SARS-CoV-2 infection by reverse transcription polymerase chain reaction nucleic acid testing. Outcomes of these women were compared with their familial/household members with contact to the affected patient on or after their symptom onset. All data were reported at death or after a minimum of 14 days from date of admission with COVID-19 disease.

Results: Among 9 pregnant women with severe COVID-19 disease, at the time of reporting, 7 of 9 died, 1 of 9 remains critically ill and ventilator dependent, and 1 of 9 recovered after prolonged hospitalization. We obtained self-verified familial/household cohort data in all 9 cases, and in each and every instance, maternal outcomes were more severe compared with outcomes of other high- and low-risk familial/household members (n=33 members for comparison).

Conclusion: We report herein maternal deaths owing to COVID-19 disease. Until rigorously collected surveillance data emerge, it is prudent to be aware of the potential for maternal death among pregnant women diagnosed as having COVID-19 disease in their second or third trimester.

Citing Articles

Analysing space-time patterns of maternal mortality attributed to anaemia in Karnataka, India: a spatial epidemiological study.

K S S, G B, Basavegowda M, D S, M C M, D V S K M BMJ Public Health. 2025; 2(2):e000590.

PMID: 40018549 PMC: 11816185. DOI: 10.1136/bmjph-2023-000590.

Infection with SARS-CoV-2 during the first trimester did not adversely impact perinatal and obstetric outcomes subsequent to in vitro fertilization with frozen embryo transfer: a retrospective cohort study.

Zhang J, Ye J, Gao H, Mao X, Wu L J Assist Reprod Genet. 2025; 42(2):589-598.

PMID: 39820830 PMC: 11871260. DOI: 10.1007/s10815-025-03390-z.

COVID-19 and pregnancy: a comprehensive study of comorbidities and outcomes.

Zhou S, Ahmadi H, Huo L, Lix L, Maslin K, Latour J BMC Public Health. 2024; 24(1):3157.

PMID: 39538148 PMC: 11562717. DOI: 10.1186/s12889-024-20416-w.

Access to and Utilization of Maternal and Child Healthcare Services During COVID-19 Pandemic in Rural Bangladesh.

Matiur Rahman M, Siddique M, Rahman M, Islam M, Ur Rahim M Int J MCH AIDS. 2024; 13:e018.

PMID: 39526169 PMC: 11544479. DOI: 10.25259/IJMA_612.

Evaluation of the Relationship between Early Clinical Manifestations and Changes in Biochemical, Inflammatory, and Coagulation Parameters and the Prognosis of Pregnant Women with COVID-19 Admitted to the ICU.

Ebrahim Babai M, Kabiri A, Movahedi M, Ghahiri A, Hajhashemi M, Dehghan M Adv Biomed Res. 2024; 13:76.

PMID: 39512403 PMC: 11542693. DOI: 10.4103/abr.abr_257_23.

References

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Pringle K, Tadros M, Callister R, Lumbers E . The expression and localization of the human placental prorenin/renin-angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis?. Placenta. 2011; 32(12):956-62. DOI: 10.1016/j.placenta.2011.09.020. View

Mizumoto K, Chowell G . Estimating Risk for Death from Coronavirus Disease, China, January-February 2020. Emerg Infect Dis. 2020; 26(6):1251-1256. PMC: 7258458. DOI: 10.3201/eid2606.200233. View

Liu D, Li L, Wu X, Zheng D, Wang J, Yang L . Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis. AJR Am J Roentgenol. 2020; 215(1):127-132. DOI: 10.2214/AJR.20.23072. View

Aagaard-Tillery K, Silver R, Dalton J . Immunology of normal pregnancy. Semin Fetal Neonatal Med. 2006; 11(5):279-95. DOI: 10.1016/j.siny.2006.04.003. View

Mosby L, Rasmussen S, Jamieson D . 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol. 2011; 205(1):10-8. DOI: 10.1016/j.ajog.2010.12.033. View

Gagneur A, Dirson E, Audebert S, Vallet S, Legrand-Quillien M, Laurent Y . Materno-fetal transmission of human coronaviruses: a prospective pilot study. Eur J Clin Microbiol Infect Dis. 2008; 27(9):863-6. PMC: 7087967. DOI: 10.1007/s10096-008-0505-7. View

Zeng H, Xu C, Fan J, Tang Y, Deng Q, Zhang W . Antibodies in Infants Born to Mothers With COVID-19 Pneumonia. JAMA. 2020; 323(18):1848-1849. PMC: 7099444. DOI: 10.1001/jama.2020.4861. View

Wen R, Sun Y, Xing Q . A patient with SARS-CoV-2 infection during pregnancy in Qingdao, China. J Microbiol Immunol Infect. 2020; 53(3):499-500. PMC: 7128446. DOI: 10.1016/j.jmii.2020.03.004. View

10.

Vincent M, Bergeron E, Benjannet S, Erickson B, Rollin P, Ksiazek T . Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005; 2:69. PMC: 1232869. DOI: 10.1186/1743-422X-2-69. View

11.

Zeng L, Xia S, Yuan W, Yan K, Xiao F, Shao J . Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China. JAMA Pediatr. 2020; 174(7):722-725. PMC: 7099530. DOI: 10.1001/jamapediatrics.2020.0878. View

12.

Lukassen S, Chua R, Trefzer T, Kahn N, Schneider M, Muley T . SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. EMBO J. 2020; 39(10):e105114. PMC: 7232010. DOI: 10.15252/embj.20105114. View

13.

Littauer E, Skountzou I . Hormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy. Front Immunol. 2018; 9:2455. PMC: 6215819. DOI: 10.3389/fimmu.2018.02455. View

14.

Liu Y, Chen H, Tang K, Guo Y . Withdrawn: Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect. 2020; . PMC: 7133645. DOI: 10.1016/j.jinf.2020.02.028. View

15.

Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H . Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology. 2020; 158(6):1831-1833.e3. PMC: 7130181. DOI: 10.1053/j.gastro.2020.02.055. View

16.

Wong S, Chow K, Leung T, Ng W, Ng T, Shek C . Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004; 191(1):292-7. PMC: 7137614. DOI: 10.1016/j.ajog.2003.11.019. View

17.

Wang S, Guo L, Chen L, Liu W, Cao Y, Zhang J . A Case Report of Neonatal 2019 Coronavirus Disease in China. Clin Infect Dis. 2020; 71(15):853-857. PMC: 7108144. DOI: 10.1093/cid/ciaa225. View

18.

Paton N, Goodall R, Dunn D, Franzen S, Collaco-Moraes Y, Gazzard B . Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial. JAMA. 2012; 308(4):353-61. PMC: 3821003. DOI: 10.1001/jama.2012.6936. View

19.

Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X . Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis. 2020; 20(5):559-564. PMC: 7158904. DOI: 10.1016/S1473-3099(20)30176-6. View

20.

Ng W, Wong S, Lam A, Mak Y, Yao H, Lee K . The placentas of patients with severe acute respiratory syndrome: a pathophysiological evaluation. Pathology. 2006; 38(3):210-8. PMC: 7131423. DOI: 10.1080/00313020600696280. View